Oric Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Oric Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- South SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ORIC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001796280
- EIN
- 47-1787157
Board of directors
-
Angie You · DirectorSince 2023
-
Jacob Chacko · Director · PRESIDENT AND CEOSince 2023
-
Lori Anne Kunkel · DirectorSince 2023
-
Mardi Dier · DirectorSince 2023
-
Richard A. Heyman · DirectorSince 2023
-
Steven L. Hoerter · DirectorSince 2023
Chief executives
Jacob Chacko
· President and CEO
Dates unknown
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.4%
-
99.6%
Board connections
6 of this board's directors also sit on 9 other boards.
- via Lori Anne Kunkel and Richard A. Heyman
- via Jacob Chacko
- via Angie You
- via Steven L. Hoerter
- via Steven L. Hoerter
- via Lori Anne Kunkel
- via Richard A. Heyman
- via Mardi Dier
- via Steven L. Hoerter
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $4,177,217
- 16 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Option exercise | +600 | $4.36 | $2,616 |
| Sep 24, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Open-market sale | −100 | $13.50 | $1,350 |
| Sep 24, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Open-market sale | −500 | $13.51 | $6,753 |
| Aug 26, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Option exercise | +52,000 | $4.36 | $226,720 |
| Aug 26, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Option exercise | +25,000 | $6.00 | $150,000 |
| Aug 26, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Open-market sale | −77,000 | $13.69 | $1,053,814 |
| Jul 24, 2026 | Richard A. Heyman Director | Option exercise | +3,500 | $1.60 | $5,600 |
| Jul 24, 2026 | Richard A. Heyman Director | Open-market sale | −7,000 | $12.02 | $84,140 |
| Jul 24, 2026 | Richard A. Heyman Director | Open-market sale | −6,100 | $12.02 | $73,322 |
| Jul 6, 2026 | Richard A. Heyman Director | Open-market sale | −300 | $12.00 | $3,600 |
| Feb 24, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Option exercise | +52,000 | $4.36 | $226,720 |
| Feb 24, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Open-market sale | −52,000 | $13.51 | $702,520 |
| Jan 16, 2026 | Richard A. Heyman Director | Open-market sale | −3,500 | $12.00 | $42,000 |
| Jan 16, 2026 | Richard A. Heyman Director | Open-market sale | −3,200 | $12.00 | $38,400 |
| Dec 16, 2025 | Pratik S. Multani Officer (Chief Medical Officer) | Open-market sale | −10,720 | $9.06 | $97,123 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.